Ciprofloxacin vs Nivolumab

Ciprofloxacin vs Nivolumab: Overview

This comparison examines the pharmacological differences between Ciprofloxacin and Nivolumab.

Mechanism of Action

Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Ciprofloxacin — 4 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Ciprofloxacin — C17H18FN3O3.

Molecular Weight: Ciprofloxacin — 331.3460 g/mol.

Type: Ciprofloxacin — Small molecule; Nivolumab — Antibody.